Our Milton Keynes site serves as the UK network headquarters, supporting Phase 2 to Phase 4 clinical trials across a wide range of therapeutic areas, including vaccines, pulmonary diseases, cardiovascular diseases, metabolic disorders, dermatology, mental health, and many other areas. The site is operated by an experienced team of investigators and research staff dedicated to delivering high-quality data, ensuring patient safety, and achieving recruitment goals.

We work closely with local healthcare providers and community groups to enrol participants from diverse backgrounds. With strong operational processes in place, Milton Keynes provides reliable support for sponsors and CROs seeking timely, high-quality trial execution.